Unknown

Dataset Information

0

Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk.

ABSTRACT: The abundance of Lp(a) protein holds significant implications for the risk of cardiovascular disease (CVD), which is directly impacted by the copy number (CN) of KIV-2, a 5.5 kbp sub-region. KIV-2 is highly polymorphic in the population and accurate analysis is challenging. In this study, we present the DRAGEN KIV-2 CN caller, which utilizes short reads. Data across 166 WGS show that the caller has high accuracy, compared to optical mapping and can further phase ~50% of the samples. We compared KIV-2 CN numbers to 24 previously postulated KIV-2 relevant SNVs, revealing that many are ineffective predictors of KIV-2 copy number. Population studies, including USA-based cohorts, showed distinct KIV-2 CN, distributions for European-, African-, and Hispanic-American populations and further underscored the limitations of SNV predictors. We demonstrate that the CN estimates correlate significantly with the available Lp(a) protein levels and that phasing is highly important.

SUBMITTER: Behera S 

PROVIDER: S-EPMC10168217 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The abundance of Lp(a) protein holds significant implications for the risk of cardiovascular disease (CVD), which is directly impacted by the copy number (CN) of KIV-2, a 5.5 kbp sub-region. KIV-2 is highly polymorphic in the population and accurate analysis is challenging. In this study, we present the DRAGEN KIV-2 CN caller, which utilizes short reads. Data across 166 WGS show that the caller has high accuracy, compared to optical mapping and can further phase ~50% of the samples. We compared  ...[more]

Similar Datasets

Unknown Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk.
| S-EPMC11515395 | biostudies-literature
Unknown A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
| S-EPMC5837733 | biostudies-literature
Unknown Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.
| S-EPMC2914160 | biostudies-literature
Unknown Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
| S-EPMC7400957 | biostudies-literature
Unknown Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function.
| S-EPMC7152747 | biostudies-literature
Unknown Prevalence of Lp(a) in a real-world Portuguese cohort: implications for cardiovascular risk assessment.
| S-EPMC11742203 | biostudies-literature
Unknown Impact of allele-specific peptides in proteome quantification.
| S-EPMC4448739 | biostudies-literature
Unknown Lp-PLA2 Inhibitors for the Reduction of Cardiovascular Events.
| S-EPMC4107429 | biostudies-literature
Unknown Increasing provider awareness of Lp(a) testing for patients at risk for cardiovascular disease: A comparative study.
| S-EPMC11666892 | biostudies-literature
Unknown Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs.
| S-EPMC2765218 | biostudies-literature